NCT03689881

Brief Summary

Spondyloarthropathies (SpAs) are chronic inflammatory diseases encompassing ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthropathy, and undifferentiated SpA. In 2001, the estimated prevalence of SpA was 1.5% worldwide. Sacroiliitis is a condition caused by inflammation within the sacroiliac joint. It is the most frequent damage of SpA depicted at imaging evaluation. Conventional radiography (X-ray) is usually used to depict the structural changes associated with sacroiliitis. However further evaluation often requires additionnal computed tomography (CT). Tomosynthesis is an Xray-based imaging technology which allows reconstruction of multiple section images from a set of projection images acquired as the x-ray tube moves along a prescribed path. The advantagee of tomosynthesis is the significant reduction of radiation dose exposure compared to CT Tomosynthesis is currently used in the field of breast imaging and pneumology. Very few studies have examined the value of tomosynthesis for osteoarticular imaging. The study aims at evaluating the diagnostic performances of tomosynthesis as compared to standard X-ray and CT, in patients with a clinical suspicion of sacroiliitis. the investigators hypothesize that tomosynthesis is superior to conventional radiography for detection of sacroiliitis and is at least equal to CT with lower irradiation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

October 4, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

September 27, 2019

Status Verified

September 1, 2018

Enrollment Period

1.2 years

First QC Date

September 27, 2018

Last Update Submit

September 26, 2019

Conditions

Keywords

SacroiliitisSI jointtomosynthesisCTXray

Outcome Measures

Primary Outcomes (1)

  • Presence of bone erosions and other structural lesions of SI joints

    sacroiliitis will be assessed independently for each imaging modality according to the modified New York criteria

    1 day of enrollment

Secondary Outcomes (2)

  • radiation dose

    1 day of enrollment

  • inter reader agreement for the evaluation of sacroiliitis at tomosynthesis

    at the end of patients enrollment

Study Arms (1)

Tomosynthesis

EXPERIMENTAL

Tomosynthesis of SI joints

Device: Tomosynthesis of SI joints

Interventions

All patients will undergo additional tomosynthesis performed per study protocol along with Xray and CT performed as part of standard imaging evaluation of sacroillitis. Tomosynthesis of SI joints will be performed on a digital Tomosynthesis system (PLATINUM dRF v2 DMS/APELEM), with a single acquisition followed by coronal image reconstruction.

Tomosynthesis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 and over referred for suspected sacroiliitis.
  • Patients who have entered into their participation agreement by signing the informed consent form.
  • Patient affiliated to a social security scheme or beneficiary.

You may not qualify if:

  • Pregnant or lactating women.
  • Vulnerable people according.
  • Major people placed under guardianship or curatorship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imaging department- University hospital

Montpellier, 34295, France

RECRUITING

MeSH Terms

Conditions

Sacroiliitis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Catherine Cyteval, MD, PhD

    Montpellier University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Catherine Cyteval, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2018

First Posted

October 1, 2018

Study Start

October 4, 2018

Primary Completion

December 31, 2019

Study Completion

December 31, 2020

Last Updated

September 27, 2019

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations